Article Text

FRI0715 Being a woman and having knee osteoarthritis increases the likelihood of comorbidities
  1. M Herrero Barbero1,
  2. S Gimenez2,
  3. J Vergara3,
  4. E I Lladό Viles4,
  5. H Martinez4,
  6. G Rodríguez Roca5,
  7. L Sánchez6,
  8. JA Muñoz Díaz7,
  9. JF Frias8,
  10. A Castaño9,
  11. JJ Díaz Jiménez10,
  12. Ά de Cossío Rodríguez11,
  13. R Belenguer12,
  14. JL Llisterri13,
  15. J Vergés Milano6,14,
  16. on behalf of EMARTRO
  1. 1Plaça Francesc Macià 7, Bioiberica, Barcelona
  2. 2Unidad de Gestiόn Clínica el Limonar, Malaga
  3. 3Centro de Salud Huercal, Almería
  4. 4Bioiberica S.A., Barcelona
  5. 5Centro de Salud la Puebla de Montalbán, Toledo
  6. 6Bioiberica, Barcelona
  7. 7Centro de Salud Άvila Rural, Άvila
  8. 8Hospital Universitario Virgen de las Nieves, Granada
  9. 9Centro de Salud Corella, Navarra
  10. 10Centro de Salud Los Cubos, Burgos
  11. 11Centro de Salud San Martin de la Vega, Madrid
  12. 12Centro de Salud Algemesí
  13. 13Centro de Salud Ingeniero Joaquín Belloch, Valencia
  14. 14Osteoarthritis Fundation International, Barcelona, Spain


Background Osteoarthritis (OA) is the most prevalent joint disease and the leading cause of disability from 60 years onwards. In fact, 14,8% of the Spanish population has OA.

Objectives This study aimed to determine if there is a differential profile and greater comorbidity in women affected by symptomatic knee OA compared to a control group without OA.

Methods The EMARTRO study was designed as an observational, multicenter, transversal study to compare probability of suffering a comorbidities based on presence of symptomatic knee OA visited by GPs. Sociodemographic, anthropometric, clinical parameters and clinical variables of interest were recorded. The probability of suffering comorbidities in each study group was estimated using the Odds Ratio estimation with conditioned logistic regression models. The HAD scale, the Goldberg health questionnaire were administered to patients and the concomitant medication was also registered. The comparison between groups was done using t-Student, Chi-square and Mann-Whitney.

Results A total of 897 women were included with a mean (SD) age of 67.4 (6.8) years.

Osteoarthritic women were obese and had a higher BMI compared with control group, 31.2 (5.5) vs 27.5 (4.3) (p<0.0001), respectively. Regarding blood pressure, no differences were found in the systolic BP (p=0.0646) but in the diastolic, women with OA also had higher values, 77.9 (9.1) vs 75.8 (8.9) mmHg (p=0.0005).

In general terms, the presence of OA doubled the probability of having concomitant conditions with respect to controls [OR=2,220 (95% CI: 1,449–3,400) p=0,0002]. Likewise, women with syntomatic knee OA were more likely to have hypertension [OR=1.697 (95% CI 1.299–2.217), p=0.0001], venous peripheral vascular disease [OR=2.148 (95% CI 1.547–2.984), p<0.0001] and gastroesophageal reflux (OR=1.890 (95% CI 1.297–2.754), p=0.0009).

Regarding the mental health of the patients, according to the Goldberg scale, 41% of the patients with OA elicited psychopathology vs 17.8% in controls, p<0.0001. As for the HAD scale, there were more cases of anxiety (p<0.0001) and depression in the OA women (p<0.0001).

The greater burden of physical and mental comorbidity in the OA patients was accompanied by a higher consumption of concomitant medications (p<0.0001).

Conclusions The results of the present study indicate that in patients with knee OA, being female is a risk factor for the development of concomitant pathologies. Also, the increased likelihood of suffering from hypertension, venous peripheral vascular disease and gastroesophageal reflux should determine chronic medications for the treatment of osteoarthritis.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.